Evidence map›Paper›PMID 42531326›Full record

ArticlePLoS pathogens2026

ddOTs: A multiplexed quantitative ddPCR approach for resolving overlapping hepatitis B virus transcripts to decipher cccDNA-driven transcription.

Nazim Sarica, Oceane Lopez, João Diogo Dias, Victor Boschetti, Irene Meki, Basile Jay, Gael Petitjean, David Durantel, Christine Neuveut

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nazim SaricaInstitut de Génétique Humaine. Laboratoire de Virologie Moléculaire, Université de Montpellier, CNRS, Montpellier, France.
Oceane LopezInstitut de Génétique Humaine. Laboratoire de Virologie Moléculaire, Université de Montpellier, CNRS, Montpellier, France.ORCID 0009-0009-4921-4580
João Diogo DiasInstitut de Génétique Humaine. Laboratoire de Virologie Moléculaire, Université de Montpellier, CNRS, Montpellier, France.
Victor BoschettiCentre International de Recherche en Infectiologie (CIRI), INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, France.ORCID 0009-0007-3536-660X
Irene MekiInstitut de Génétique Humaine. Laboratoire de Virologie Moléculaire, Université de Montpellier, CNRS, Montpellier, France.
Basile JayInstitut de Génétique Humaine. Laboratoire de Virologie Moléculaire, Université de Montpellier, CNRS, Montpellier, France.ORCID 0000-0001-8573-8722
Gael PetitjeanInstitut de Génétique Humaine. Laboratoire de Virologie Moléculaire, Université de Montpellier, CNRS, Montpellier, France.
David DurantelCentre International de Recherche en Infectiologie (CIRI), INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, France.
Christine NeuveutInstitut de Génétique Humaine. Laboratoire de Virologie Moléculaire, Université de Montpellier, CNRS, INSERM, Montpellier, France.ORCID 0000-0001-6520-271X

Funding

Agence Nationale de la Recherche sur le SIDAde la Recherche et de l’InnovationMinistère de l’Enseignement supérieur
6 · The paper itself

Abstract

Chronic hepatitis B virus infection persists as a global health crisis, driving life-threatening liver pathologies such as hepatocellular carcinoma. Central to HBV's resilience is the covalently closed circular DNA (cccDNA), a viral minichromosome that orchestrates viral transcription and sustains infection. Dissecting cccDNA-driven transcription remains a formidable challenge due to the dense overlap of viral open reading frames, which generates RNA transcripts with shared sequences, complicating precise quantification and hindering efforts to unravel HBV's transcriptional regulation. To address this bottleneck, we developed a multiplexed assay named ddPCR for Overlapping Transcripts (ddOTs) capable of simultaneously quantifying all major HBV RNA species, including splice variants, with unprecedented specificity and sensitivity. This method overcomes current limitations by leveraging the high-resolution power of ddPCR to deconvolute overlapping transcripts, enabling direct interrogation of individual promoter/enhancer activities and RNA stability. By offering a cost-effective, scalable solution for precise RNA profiling in rare biological samples, this breakthrough tool unlocks new avenues for exploring cccDNA biology and accelerating antiviral drug development.

Indexed as

DNA, CircularDNA, ViralHepatitis B, ChronicHepatitis B virusPolymerase Chain ReactionRNA, ViralTranscription, GeneticViral TranscriptionGene Expression Regulation, ViralHumansVirus ReplicationDNA, CircularDNA, ViralRNA, Viral

Identifiers

PMID42531326
PMCPMC13450838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.